Cary Street Partners’s Eli Lilly LLY Stock Holding History

Cary Street Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.1M	Buy	30,891 +3,318	+12%	+$3.39M	0.81%	21
2026 Q1	$25.4M	Sell	27,573 -970	-3%	-$983K	0.63%	35
2025 Q4	$30.7M	Buy	28,543 +492	+2%	+$470K	0.76%	25
2025 Q3	$21.4M	Buy	28,051 +2,999	+12%	+$2.23M	0.56%	39
2025 Q2	$19.5M	Sell	25,052 -894	-3%	-$695K	0.55%	40
2025 Q1	$21.4M	Sell	25,946 -393	-1%	-$327K	0.68%	29
2024 Q4	$20.3M	Buy	+26,339	New	+$21.8M	0.66%	35

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Cary Street Partners's LLY Position: Q2 2026 in Review

Cary Street Partners increased its Eli Lilly (LLY) stake by 12% in Q2 2026, buying an estimated $3.39M and bringing the position to 30,891 shares worth $37.1M. The position accounts for 0.81% of the portfolio, ranked #21.

Cary Street Partners first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Cary Street Partners held 30,891 shares of Eli Lilly worth $37.1M as of Q2 2026.
Cary Street Partners bought 3,318 Eli Lilly shares in Q2 2026, an estimated $3.39M.
Eli Lilly made up 0.81% of Cary Street Partners's portfolio in Q2 2026, its #21 holding.
Cary Street Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.